Clinical Trial Update: Schizotypal Personality Disorder Risperidone [Phase 1, Phase 2]

View source ↗

Summary

Phase 1 and Phase 2 studies evaluating risperidone for schizotypal personality disorder have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizotypal Personality Disorder

Drugs mentioned

• Risperdal (risperidone)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Schizotypal Personality Disorder | Phase 1, Phase 2 | Status: COMPLETED